rx2

CGRP
A New Class of Drugs
What to Know About the New Anti CGRP
Migraine Treatment Options
In groundbreaking news for the migraine community, the FDA recently approved
the first anti CGRP migraine treatments specifically created to prevent
migraine. Designed to target CGRP, the protein known for causing migraine,
these treatments are the biggest news in migraine treatment and
prevention in decades. With one treatment option released on the market and
three more expected in the next year and a half, migraine patients are asking
if these treatments apply to them. The American Migraine Foundation sat
down with Dr. Stewart Tepper, a professor of Neurology at the Geisel School
of Medicine at Dartmouth and Director of the Dartmouth Headache Center
at the Dartmouth-Hitchcock Medical Center, to answer the most pressing
questions surrounding the monoclonal antibodies designed to target CGRP
and the CGRP receptor.